Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 9-MTH group results

Feb 13 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             24.56               25.89            34.30    
                 (-5.1 pct)          (+14.3 pct)      (-4.3 pct)  
  Operating          3.88                3.43             6.20    
                 (+13.0 pct)        (+113.4 pct)      (+13.5 pct) 
  Recurring          3.90                3.55             6.30    
                 (+9.8 pct)         (+101.4 pct)      (+11.2 pct) 
  Net                2.71                2.09             3.70    
                 (+29.7 pct)         (+95.4 pct)      (+1.2 pct)  
  EPS             22.49 yen           17.35 yen        30.73 yen  
  Ann Div                             7.00 yen         8.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             7.00 yen         8.00 yen   
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news